Literature DB >> 19108586

Molecular modeling studies of the interaction between Plasmodium falciparum HslU and HslV subunits.

Sangeetha Subramaniam1, Asif Mohmmed, Dinesh Gupta.   

Abstract

The PfHslUV, a Plasmodium falciparum homolog of prokaryotic HslUV systems, is a newly identified drug target. The HslUV complex is an assembly of Heat Shock Locus gene products U and V. The formation of complete complex is essential for the proteasome to carry out its biochemical and physiological role in the parasite, namely to degrade specific target proteins in an ATP-dependent chaperone assisted manner. PfHslV subunit, a protease, exhibits increased proteolytic activity in the presence of PfHslU, the subunit believed to be responsible for allosteric activation of PfHslV. In the present work, we have employed computational methods to simulate the interaction of PfHslU and PfHslV subunits. We have used three methods--namely homology modeling, molecular docking and computational alanine scanning to model the complex, to predict the binding mode of PfHslU-V interaction and to predict the binding-energy hot-spots in protein-protein interface, respectively. The three dimensional models of PfHslV and PfHslU have been generated using MODELLER, based on the crystal structures of prokaryotic HslUV complex as templates. The modeled structures were docked using PatchDock, a geometry-based molecular docking algorithm. Finally, a three-dimensional PfHslUV complex model was generated that helped in comparing protein-protein interface characteristics with that of crystal structures of prokaryotic HslUV. Further, computational alanine scanning analysis of the generated complex was performed to calculate the binding free energy changes (DeltaDeltaGbind), which helped in identifying residues crucial for PfHslU and PfHslV interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19108586     DOI: 10.1080/07391102.2009.10507262

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  7 in total

1.  Interaction between shrimp and white spot syndrome virus through PmRab7-VP28 complex: an insight using simulation and docking studies.

Authors:  Arunima Kumar Verma; Shipra Gupta; Sharad Verma; Abha Mishra; N S Nagpure; Shivesh Pratap Singh; Ajey Kumar Pathak; Uttam Kumar Sarkar; Shri Prakash Singh; Mahender Singh; Prahlad Kishore Seth
Journal:  J Mol Model       Date:  2012-11-23       Impact factor: 1.810

2.  A conformationally constrained peptidomimetic binds to the extracellular region of HER2 protein.

Authors:  Sashikanth Banappagari; Sharon Ronald; Seetharama D Satyanarayanajois
Journal:  J Biomol Struct Dyn       Date:  2010-12

Review 3.  Protein Degradation Systems as Antimalarial Therapeutic Targets.

Authors:  Caroline L Ng; David A Fidock; Matthew Bogyo
Journal:  Trends Parasitol       Date:  2017-07-05

4.  Approaching the 5-HT₃ receptor heterogeneity by computational studies of the transmembrane and intracellular domains.

Authors:  Marta Del Cadia; Francesca De Rienzo; Maria Cristina Menziani
Journal:  J Comput Aided Mol Des       Date:  2013-06-16       Impact factor: 3.686

Review 5.  The proteasome of malaria parasites: A multi-stage drug target for chemotherapeutic intervention?

Authors:  Makoah Nigel Aminake; Hans-Dieter Arndt; Gabriele Pradel
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-01-09       Impact factor: 4.077

6.  Disruption of a mitochondrial protease machinery in Plasmodium falciparum is an intrinsic signal for parasite cell death.

Authors:  S Rathore; S Jain; D Sinha; M Gupta; M Asad; A Srivastava; M S Narayanan; G Ramasamy; V S Chauhan; D Gupta; A Mohmmed
Journal:  Cell Death Dis       Date:  2011-11-24       Impact factor: 8.469

7.  Interaction between Nbp35 and Cfd1 proteins of cytosolic Fe-S cluster assembly reveals a stable complex formation in Entamoeba histolytica.

Authors:  Shadab Anwar; Manas Ranjan Dikhit; Krishn Pratap Singh; Rajiv Kumar Kar; Amir Zaidi; Ganesh Chandra Sahoo; Awadh Kishore Roy; Tomoyoshi Nozaki; Pradeep Das; Vahab Ali
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.